Symposium on Hidradenitis Suppurativa Advances 2025 Proceedings

This is the authors' abstract. We don't add key points for this paper.

The 10th Annual Symposium on Hidradenitis Suppurativa Advances (SHSA) was held in Nashville, TN, USA, from 31 October to 2 November 2025. The symposium was jointly hosted by the US Hidradenitis Suppurativa Foundation (HSF) and the Canadian HS Foundation (CHSF), with Dr. Vincent Piguet serving as the 2025 SHSA Planning Chair and Dr. Martina Porter serving as Vice Chair. The conference featured presentations from experts in hidradenitis suppurativa (HS) across multiple disciplines, coming together to discuss the recent scientific, pharmaceutical, and technological advancements in our understanding and management of HS. Panelists and presenters discussed new perspectives on HS pathogenesis, management of complex medical cases, procedural interventions, and novel biologic and small-molecule therapeutic agents in the pipeline, among several other topics. SHSA is the largest research-focused HS conference in North America, with 537 attendees from 18 countries, and over 30 individuals living with HS in attendance at the 10th annual meeting. The symposium featured five plenary talks, four expert panel discussions, procedural and ultrasound workshops, and selected oral abstract presentations, including a late breaking abstract session that included top-line data from phase 3 clinical trials being presented at a conference for the first time. The following proceedings are a summary of highlights from the plenary sessions, panels, and select late-breaking abstracts presented at the conference. The complete anthology of abstracts presented at SHSA 2025 has been published [ 1 ]. This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.